The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma

Journal of Hepatology

Volumn 65, Issue 6, 2016, Pages 1272-1273

  Minami, Tatsuya ^a   Tateishi, Ryosuke ^a   Nakagomi, Ryo ^a   Fujiwara, Naoto ^a   Sato, Masaya ^a   Enooku, Kenichiro ^a   Nakagawa, Hayato ^a   Asaoka, Yoshinari ^a   Kondo, Yuji ^a   Shiina, Shuichiro ^b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; ALPHA FETOPROTEIN; ASUNAPREVIR; DACLATASVIR; DECARBOXYPROTHROMBIN; INTERFERON; LEDIPASVIR; RIBAVIRIN; SOFOSBUVIR; ANTIVIRUS AGENT;

ADULT; AGED; ALPHA FETOPROTEIN BLOOD LEVEL; ANTIVIRAL THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LENTIL; LETTER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR ABLATION; CATHETER ABLATION; LIVER TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 84994545285     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.07.043     Document Type: Letter

References (3)

1. [1] Reig, M., Marino, Z., Perello, C., Inarrairaegui, M., Ribeiro, A., Lens, S., et al. Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution. J Hepatol 65 (2016), 719–726.
2. [2] Shiina, S., Tateishi, R., Arano, T., Uchino, K., Enooku, K., Nakagawa, H., et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 107 (2012), 569–577 [Quiz 578].
3. [3] Shen, Y.C., Hsu, C., Chen, L.T., Cheng, C.C., Hu, F.C., Cheng, A.L., Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol 52 (2010), 889–894.